Drugs / IFN-α
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01191034 | Aug 2010 → Aug 2012 | metastatic melanoma | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IFN-α | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01191034 ↗ |
| Route | Other | “peritumoral injection of IL-2, IFN-α and GM-CSF” NCT01191034 ↗ |